1. Home
  2. BTAI vs NHTC Comparison

BTAI vs NHTC Comparison

Compare BTAI & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTAI
  • NHTC
  • Stock Information
  • Founded
  • BTAI 2017
  • NHTC 1988
  • Country
  • BTAI United States
  • NHTC United States
  • Employees
  • BTAI N/A
  • NHTC N/A
  • Industry
  • BTAI Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • BTAI Health Care
  • NHTC Miscellaneous
  • Exchange
  • BTAI Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • BTAI 52.7M
  • NHTC 56.0M
  • IPO Year
  • BTAI 2018
  • NHTC 1995
  • Fundamental
  • Price
  • BTAI $3.79
  • NHTC $4.57
  • Analyst Decision
  • BTAI Strong Buy
  • NHTC
  • Analyst Count
  • BTAI 4
  • NHTC 0
  • Target Price
  • BTAI $40.00
  • NHTC N/A
  • AVG Volume (30 Days)
  • BTAI 14.1M
  • NHTC 46.8K
  • Earning Date
  • BTAI 08-12-2025
  • NHTC 10-29-2025
  • Dividend Yield
  • BTAI N/A
  • NHTC 17.50%
  • EPS Growth
  • BTAI N/A
  • NHTC N/A
  • EPS
  • BTAI N/A
  • NHTC 0.03
  • Revenue
  • BTAI $868,000.00
  • NHTC $42,087,000.00
  • Revenue This Year
  • BTAI N/A
  • NHTC N/A
  • Revenue Next Year
  • BTAI $597.46
  • NHTC N/A
  • P/E Ratio
  • BTAI N/A
  • NHTC $152.30
  • Revenue Growth
  • BTAI N/A
  • NHTC N/A
  • 52 Week Low
  • BTAI $1.17
  • NHTC $4.02
  • 52 Week High
  • BTAI $13.36
  • NHTC $6.89
  • Technical
  • Relative Strength Index (RSI)
  • BTAI 48.02
  • NHTC 56.28
  • Support Level
  • BTAI $3.41
  • NHTC $4.20
  • Resistance Level
  • BTAI $4.20
  • NHTC $4.45
  • Average True Range (ATR)
  • BTAI 0.62
  • NHTC 0.12
  • MACD
  • BTAI -0.27
  • NHTC 0.02
  • Stochastic Oscillator
  • BTAI 11.05
  • NHTC 84.16

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: